Cough – Pipeline Review, H2 Market Research Report 2017

Posted on 2017-09-01 by Mark Hub in Healthcare // 0 Comments

Albany, US, 2017-Sep-01 — /EPR Network/ —Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Cough – Pipeline Review, H2 2017”. Cough is a common reflex action that aims to clear the throat of mucus or foreign irritants. Dry cough, chronic cough and whooping cough (also known as pertussis) are distinct types of cough. Symptoms include runny or stuffy nose, hoarseness, wheezing and shortness of breath, heartburn or a sour taste in mouth and rarely coughing up blood.

Request For Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1313673

The predisposing factors include asthma, chronic obstructive pulmonary disease, cigarette smoking, lung diseases such as bronchiectasis, interstitial lung disease, or tumors, lung infections such as pneumonia or acute bronchitis and allergic rhino sinusitis. Treatment includes cough suppressants, oral expectorants, and topical (externally applied) drugs.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Cough – Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Cough (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 1, 7, 1, 10, 3 and 4 respectively.

Cough (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Cough (Respiratory).
– The pipeline guide reviews pipeline therapeutics for Cough (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Cough (Respiratory) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Cough (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Cough (Respiratory)

Reasons to buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Cough (Respiratory).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Cough (Respiratory) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Browse Full Report With TOC: http://www.marketresearchhub.com/report/cough-pipeline-review-h2-2017-report.html

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Cough – Overview
Cough – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Cough – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cough – Companies Involved in Therapeutics Development
Alitair Pharmaceuticals Inc
AstraZeneca Plc
BELLUS Health Inc
Charleston Laboratories Inc
Conrig Pharma ApS
Daewoong Pharmaceutical Co Ltd
Develco Pharma Schweiz AG
Grunenthal GmbH
Hyundai Pharmaceutical Co Ltd
Merck & Co Inc
Orbis Biosciences Inc
Patara Pharma Inc
PhytoHealth Corp
Pila Pharma AB
SolAeroMed Inc
Vernalis Plc
Cough – Drug Profiles
AX-8 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
benzonatate – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BLU-5937 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCP-05 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CCP-06 – Drug Profile
Product Description
Mechanism Of Action

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1313673

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick